Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal ion channels constitute a diverse class of membrane proteins responsible for controlling ion flow across intestinal epithelial cells, smooth muscle, and immune cells. This functional class includes multiple molecular subtypes—such as voltage-gated potassium channels (Kv), calcium-activated potassium channels (KCa), inwardly rectifying potassium channels (Kir), two-pore domain channels (K2P), and chloride channels—each with distinct tissue distribution, regulation, and physiological roles[1][2]. These channels mediate essential functions including ion homeostasis, epithelial secretion and absorption, smooth muscle contraction, immune cell activation, and barrier maintenance[1][3][4].\n\nIntestinal ion channels are implicated in gastrointestinal disease through multiple mechanisms: during inflammation, channel expression and function are remodeled through phosphorylation, oxidative modifications, and proteasomal degradation, contributing to altered motility and secretion[1]; ion channelopathies underlie functional gastrointestinal disorders characterized by dysmotility or secretory dysfunction[9]; and specific channels regulate immune responses in the gut[3]. Therapeutic targeting of intestinal ion channels presents both opportunities and challenges: multiple pharmacological modulators exist for different channel subtypes, but their clinical development is constrained by off-target effects on cardiac, vascular, and other tissues, making channel subtype selectivity a critical safety consideration[8]. For drug development, targeting individual channel subtypes (e.g., KCa3.1, KCNQ1) rather than the broad functional class is necessary for achieving therapeutic efficacy with acceptable safety profiles.
Channel Modulation Mechanisms\n- Phosphorylation/dephosphorylation — Serine/threonine and tyrosine kinases (e.g., c-src kinase, protein kinase A, PKC, CAMKII) regulate channel phosphorylation state, affecting gating kinetics and current amplitude\n- Oxidative/nitrosative modifications — Cysteine thiol oxidation, nitrosylation, and tyrosine nitration alter channel function in response to oxidative stress\n- Ubiquitin-proteasome degradation — E3 ligases (e.g., Nedd4 family) target channels for ubiquitylation and proteasomal degradation, reducing channel expression\n- Altered mRNA stability and trafficking — Changes in mRNA expression and membrane localization affect functional channel abundance\n- Direct ligand binding — Some channels respond to metabolites (ATP for Kir channels) or inflammatory mediators that shift activation thresholds\n- Voltage sensing — Voltage-gated channels respond to changes in membrane potential through transmembrane voltage sensor domains
41 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal ion channel (None standardized; the term encompasses multiple specific channel types).